Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.4, 2013-07, pp. : 455-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus for the treatment of advanced renal cell carcinoma

By Amato Robert

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1143-1155

Informa Healthcare

Access to resources Recommend Favorite

Targeted Agents for the Treatment of Advanced Renal Cell Carcinoma

Current Drug Targets, Vol. 6, Iss. 7, 2005-11 ,pp. : 835-846

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma

By Shaheen Philip Stadler Walter Elson Paul Knox Jennifer Winquist Eric Bukowski Ronald

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 577-581

Springer Publishing Company

Access to resources Recommend Favorite

Targeting angiogenesis in renal cell carcinoma

By Posadas Edwin M Limvorasak Suwicha Sharma Shaleekha Figlin Robert A

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2221-2236

Informa Healthcare

Access to resources Recommend Favorite

Targeting Angiogenesis in Renal Cell Carcinoma

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 349-358

Bentham Science Publishers

Access to resources Recommend Favorite